Rearrangement of PAX5 is observed in 2.5% of B-cell precursor ALL, with particular emphasis on the PAX5::JAK2 fusion, which plays an important role in tumorigenesis [111,112]. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.